Loading clinical trials...
Loading clinical trials...
A Phase 3 Trial to Evaluate the Safety, Immunogenicity, and Non-Interference With Concomitant Routine Vaccines, of a Meningococcal Serogroup ACYWX Conjugate Vaccine (NmCV-5) in Comparison With MenACWY-TT Conjugate Vaccine in Healthy Malian Infants
Conditions
Interventions
NmCV-5
MenACWY-TT
Locations
1
Mali
Centre pour le Developpement des Vaccins du Mali
Bamako, Mali
Start Date
March 24, 2022
Primary Completion Date
March 10, 2023
Completion Date
February 20, 2025
Last Updated
April 17, 2025
NCT07203755
NCT05590455
NCT05383742
NCT05777499
NCT06811025
NCT06465420
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions